GeneDx Holdings(WGS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

WGS GeneDx Holdings

休市中 04-10 16:00:00 EDT

59.62

-0.43

-0.72%

盘后59.53

-0.09-0.15%

19:56 EDT

最高62.00	最低57.29	成交量66.51万
今开60.81	昨收60.05	日振幅7.84%
总市值17.46亿	流通市值11.89亿	总股本2,929万
成交额3,928万	换手率3.33%	流通股本1,994万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"WGS","market":"US","secType":"STK","nameCN":"GeneDx Holdings","latestPrice":59.62,"timestamp":1775851200000,"preClose":60.05,"halted":0,"volume":665071,"hourTrading":{"tag":"盘后","latestPrice":59.5299,"preClose":59.62,"latestTime":"19:56 EDT","volume":7109,"amount":423824.6439,"timestamp":1775865361175,"change":-0.0901,"changeRate":-0.001511,"amplitude":0.001511},"delay":0,"changeRate":-0.007160699417152369,"floatShares":19944938,"shares":29288700,"eps":-0.733929,"marketStatus":"休市中","change":-0.43,"latestTime":"04-10 16:00:00 EDT","open":60.81,"high":62,"low":57.29,"amount":39280775.889630005,"amplitude":0.078435,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.733929,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776067200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":60.05,"preHourTrading":{"tag":"盘前","latestPrice":61,"preClose":60.05,"latestTime":"09:18 EDT","volume":853,"amount":52392.091674999996,"timestamp":1775827122968,"change":0.95,"changeRate":0.01582,"amplitude":0.066445},"postHourTrading":{"tag":"盘后","latestPrice":59.5299,"preClose":59.62,"latestTime":"19:56 EDT","volume":7109,"amount":423824.6439,"timestamp":1775865361175,"change":-0.0901,"changeRate":-0.001511,"amplitude":0.001511},"volumeRatio":0.9704358065404166,"impliedVol":1.0691,"impliedVolPercentile":0.808},"requestUrl":"/m/hq/s/WGS/wiki","defaultTab":"wiki","newsList":[{"id":"1161051546","title":"GeneDx与Zevra Therapeutics将联合推出基因检测项目，助力尼曼匹克症C型疑似患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1161051546","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161051546?lang=zh_cn&edition=full","pubTime":"2026-03-10 20:34","pubTimestamp":1773146054,"startTime":"0","endTime":"0","summary":"GeneDx Holdings宣布将与Zevra Therapeutics合作启动一项基因检测计划，旨在为疑似患有尼曼匹克症C型（Niemann-Pick disease type C）的患者提供支持。该计划致力于通过专业的基因检测服务，帮助患者及早获得明确诊断。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617630876","title":"Genedx Holdings Corp.盘中异动 早盘大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617630876","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617630876?lang=zh_cn&edition=full","pubTime":"2026-03-06 23:38","pubTimestamp":1772811517,"startTime":"0","endTime":"0","summary":"北京时间2026年03月06日23时38分，Genedx Holdings Corp.股票出现波动，股价大幅上涨5.00%。Genedx Holdings Corp.股票所在的生命科学行业中，整体跌幅为2.16%。其相关个股中，Prenetics Global、Biodesix, Inc.、Genedx Holdings Corp.涨幅较大，Xwell, Inc.、Advanced Biomed Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为4.46%、1.24%、1.03%，振幅较大的相关个股有Inotiv, Inc.、Biodesix, Inc.、Xwell, Inc.，振幅分别为15.06%、14.15%、11.72%。Genedx Holdings Corp.公司简介：GeneDx Holdings Corp提供个性化且可操作的健康洞察，为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030623383797a8ac90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030623383797a8ac90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614053126","title":"因美纳推出TruPath Genome，树立基因组洞察新标准","url":"https://stock-news.laohu8.com/highlight/detail?id=2614053126","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614053126?lang=zh_cn&edition=full","pubTime":"2026-02-25 23:06","pubTimestamp":1772031960,"startTime":"0","endTime":"0","summary":"因美纳推出TruPath Genome，树立基因组洞察新标准  凭借极简工作流程，TruPath Genome免去了传统的文库制备环节。仅需约10分钟的手动操作时间，TruPath Genome即可实现每日产出16例全基因组数据，通量几乎是同类长读长方法的两倍，同时错误更少。TruPath Genome可对高达98%的基因实现完整定相。\"凭借TruPath Genome，我们正在突破基因组学的边界，并为遗传病与罕见病研究树立新的标准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4895607_ZH95607_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["ILMN","BK4588","BK4534","BK4535","BK4585","BK4196","WGS","BK4548","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196133263","title":"异动解读 | 多家券商下调目标价，GeneDx Holdings盘中大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196133263","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196133263?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:45","pubTimestamp":1771944313,"startTime":"0","endTime":"0","summary":"GeneDx Holdings（股票代码：WGS）今日盘中股价大跌5.09%，引起了市场的关注。消息面上，多家华尔街券商在同一天下调了该公司的目标价。据路透报道，BTIG将GeneDx Holdings的目标价从200美元下调至170美元，杰富瑞将其目标价从180美元下调至150美元，Piper Sandler将其目标价从160美元下调至130美元，TD Cowen将其目标价从165美元下调至135美元。多家机构同时下调目标价，通常反映了分析师对公司未来业绩或估值的担忧，这直接影响了投资者的信心，导致了股价在交易时段内出现显著下跌。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194361823","title":"异动解读 | 第四季度业绩超预期，GeneDx Holdings盘中大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194361823","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194361823?lang=zh_cn&edition=full","pubTime":"2026-02-24 02:37","pubTimestamp":1771871836,"startTime":"0","endTime":"0","summary":"基因检测公司GeneDx Holdings今日盘中大幅上涨5.15%，表现显著强于大盘。消息面上，公司发布的第四季度财务业绩超出市场预期，是推动股价上涨的主要原因。根据报告，GeneDx第四季度营收达到1.21亿美元，高于分析师预计的1.204亿美元；调整后每股利润为14美分，也超出了每股11美分的预期。Piper Sandler的分析师指出，GeneDx在快速增长且不断扩大的罕见病检测市场中拥有独特的先发优势，增强了投资者信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150164332","title":"财报前瞻｜GeneDx Holdings本季营收预计增46.43%，机构多头占优","url":"https://stock-news.laohu8.com/highlight/detail?id=1150164332","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150164332?lang=zh_cn&edition=full","pubTime":"2026-02-16 10:58","pubTimestamp":1771210722,"startTime":"0","endTime":"0","summary":"GeneDx Holdings将在2026年02月23日发布财报，市场共识聚焦营收加速与利润弹性，本文基于最新预估与公司预披露梳理关键看点。市场一致预期GeneDx Holdings本季度营收为1.20亿美元，同比增长46.43%，调整后每股收益为0.11美元，同比下降31.43%；公司已预披露本季营收约1.21亿美元，与一致预期相当；对毛利率与净利润或净利率暂无明确一致口径，暂不展示相关数值。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜GeneDx Holdings本季营收预计增46.43%，机构多头占优","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131397710","title":"《时代》杂志将GeneDx首席执行官凯瑟琳·斯图兰列入2026年全球医疗健康领域最具影响力领袖百强榜","url":"https://stock-news.laohu8.com/highlight/detail?id=1131397710","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131397710?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:08","pubTimestamp":1770818925,"startTime":"0","endTime":"0","summary":"《时代》杂志近日公布了2026年度“TIME100健康”榜单，GeneDx Holdings公司首席执行官凯瑟琳·斯图兰荣膺其中，被评选为全球医疗健康领域最具影响力的百位领袖之一。这一殊荣彰显了她在推动基因诊断技术创新与普及方面的卓越领导力，以及对行业发展的深远贡献。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128492078","title":"GeneDx任命Linda Genen博士为首席医疗官，加速基因组学主导医疗的未来","url":"https://stock-news.laohu8.com/highlight/detail?id=1128492078","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128492078?lang=zh_cn&edition=full","pubTime":"2026-01-06 21:31","pubTimestamp":1767706273,"startTime":"0","endTime":"0","summary":"基因诊断公司GeneDx Holdings宣布，正式任命Linda Genen博士担任公司首席医疗官。此项重要人事任命旨在加速推进公司“基因组学优先”医疗护理战略的未来发展。Genen博士的加入将为公司在精准医疗领域的创新与临床实践注入强劲动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580441078","title":"Genedx Holdings Corp.2025财年第三财季实现净利润-7.64百万美元，同比增加8.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580441078","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580441078?lang=zh_cn&edition=full","pubTime":"2025-11-01 00:01","pubTimestamp":1761926464,"startTime":"0","endTime":"0","summary":"11月1日，Genedx Holdings Corp.公布财报，公告显示公司2025财年第三财季净利润为-7.64百万美元，同比增加8.06%；其中营业收入为1.17亿美元，同比增加52.21%，每股基本收益为-0.27美元。从资产负债表来看，Genedx Holdings Corp.总负债2.02亿美元，其中短期债务5.66百万美元，资产负债比为2.45，流动比率为0.03。机构评级：截至2025年11月1日，当前有9家机构对Genedx Holdings Corp.目标价做出预测，其中目标均价为151.22美元，其中最低目标价为95.00美元，最高目标价为170.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110100012094e7b7c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110100012094e7b7c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104677836","title":"异动解读 | GeneDx Holdings股价盘中大跌5.16%，尽管多家分析师上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1104677836","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104677836?lang=zh_cn&edition=full","pubTime":"2025-10-30 03:33","pubTimestamp":1761766439,"startTime":"0","endTime":"0","summary":"基因诊断公司GeneDx Holdings今日盘中股价出现大幅下跌，跌幅达5.16%，引发市场关注。这一走势与多家华尔街分析机构最新发布的研究报告形成鲜明对比。据悉，包括BTIG、杰富瑞和TD Cowen在内的多家知名投资银行均上调了GeneDx Holdings的目标股价。BTIG将目标价从140美元上调至165美元，杰富瑞从120美元上调至150美元，而TD Cowen则从140美元上调至165美元。在缺乏其他具体消息的情况下，股价下跌的原因可能涉及更广泛的市场因素或投资者情绪变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145823993","title":"异动解读 | GeneDx Holdings股价盘中大涨5.11%，多家机构上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1145823993","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145823993?lang=zh_cn&edition=full","pubTime":"2025-10-29 23:03","pubTimestamp":1761750215,"startTime":"0","endTime":"0","summary":"基因诊断公司GeneDx Holdings今日盘中股价大涨5.11%，引发市场关注。消息面上，多家华尔街机构纷纷上调了GeneDx Holdings的目标股价。GeneDx Holdings专注于罕见疾病和遗传疾病的基因诊断服务。近期该公司在技术创新和市场拓展方面取得了一系列进展，这可能是分析师上调目标价的主要原因。随着精准医疗的发展，基因诊断市场前景广阔，GeneDx Holdings作为行业领先企业有望持续受益。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141260688","title":"异动解读 | GeneDx Holdings股价盘中大涨5.43%，第三季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1141260688","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141260688?lang=zh_cn&edition=full","pubTime":"2025-10-29 01:26","pubTimestamp":1761672383,"startTime":"0","endTime":"0","summary":"基因检测公司GeneDx Holdings周二盘中股价大涨5.43%，引起投资者广泛关注。这一显著涨幅主要得益于公司发布的第三季度业绩超出市场预期。根据公司公告，GeneDx第三季度实现营业收入1.167亿美元，远超分析师预计的1.041亿美元。值得注意的是，GeneDx还上调了2025年全年收入预期，从此前的4亿至4.15亿美元提高到4.25亿至4.28亿美元。截至上一交易日收盘，GeneDx股价年内累计涨幅已达70%，显示出投资者对公司长期增长潜力的看好。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518270022","title":"Genedx Holdings Corp.盘中异动 早盘股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518270022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518270022?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613573,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Genedx Holdings Corp.股票出现异动，股价大幅下跌5.37%。截至发稿，该股报92.75美元/股，成交量2.8357万股，换手率0.10%，振幅1.32%。Genedx Holdings Corp.股票所在的生命科学行业中，整体跌幅为0.67%。Genedx Holdings Corp.公司简介：GeneDx Holdings Corp提供个性化且可操作的健康见解，为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021325398a29d24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021325398a29d24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517943185","title":"Genedx Holdings Corp.涨0.79% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517943185?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:32","pubTimestamp":1741185136,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分，Genedx Holdings Corp.股票出现波动，股价快速拉升0.79%。截至发稿，该股报99.79美元/股，成交量9781股，换手率0.03%，振幅1.31%。Genedx Holdings Corp.股票所在的生命科学行业中，整体跌幅为0.30%。Genedx Holdings Corp.公司简介：GeneDx Holdings Corp提供个性化且可操作的健康见解，为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223216a260c7b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223216a260c7b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDSX","BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677029","title":"Genedx Holdings Corp.盘中异动 早盘股价大跌5.48%报89.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677029?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:31","pubTimestamp":1741098683,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时31分，Genedx Holdings Corp.股票出现波动，股价大幅下挫5.48%。截至发稿，该股报89.18美元/股，成交量1.628万股，换手率0.06%，振幅0.14%。Genedx Holdings Corp.股票所在的生命科学行业中，整体跌幅为0.05%。Genedx Holdings Corp.公司简介：GeneDx Holdings Corp提供个性化且可操作的健康见解，为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223124a25f041c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223124a25f041c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516652666","title":"Genedx Holdings Corp.跌3.11% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516652666?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:44","pubTimestamp":1741027450,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时44分，Genedx Holdings Corp.股票出现波动，股价大幅跳水3.11%。Genedx Holdings Corp.股票所在的生命科学行业中，整体跌幅为0.73%。其相关个股中，Atlantic International Corp.、精密科学、Check-Cap Ltd.涨幅较大，23Andme Holding Co.、Mainz Biomed N.V.、Ispecimen Inc.较为活跃，换手率分别为9.79%、8.21%、7.26%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Atlantic International Corp.、Bioaffinity Technologies, Inc.，振幅分别为30.22%、25.12%、19.48%。Genedx Holdings Corp.公司简介：GeneDx Holdings Corp提供个性化且可操作的健康见解，为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304024410a25d8792&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304024410a25d8792&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514176378","title":"Genedx Holdings Corp.跌1.68% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2514176378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514176378?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753123,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Genedx Holdings Corp.股票出现异动，股价快速下跌1.68%。截至发稿，该股报99.31美元/股，成交量1.4924万股，换手率0.05%，振幅2.97%。Genedx Holdings Corp.股票所在的生命科学行业中，整体涨幅为0.64%。Genedx Holdings Corp.公司简介：GeneDx Holdings Corp提供个性化且可操作的健康见解，为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223203abe0ea80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223203abe0ea80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856062","title":"Genedx Holdings Corp.涨4.81% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856062?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:37","pubTimestamp":1740580668,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时37分，Genedx Holdings Corp.股票出现波动，股价快速拉升4.81%。Genedx Holdings Corp.股票所在的生命科学行业中，整体跌幅为0.07%。其相关个股中，Genedx Holdings Corp C/Wts 22/07/2026 、Guardant Health, Inc.、Genedx Holdings Corp.涨幅较大，Prophase Labs, Inc.、Mainz Biomed N.V.、Ispecimen Inc.较为活跃，换手率分别为4.10%、1.26%、0.99%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Prophase Labs, Inc.、Bioaffinity Technologies, Inc.，振幅分别为20.00%、10.61%、9.23%。Genedx Holdings Corp.公司简介：GeneDx Holdings Corp提供个性化且可操作的健康见解，为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262237499893abfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262237499893abfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513482720","title":"Genedx Holdings Corp.盘中异动 早盘股价大跌5.04%报91.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513482720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513482720?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:07","pubTimestamp":1740409679,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时07分，Genedx Holdings Corp.股票出现异动，股价大幅下跌5.04%。截至发稿，该股报91.00美元/股，成交量12.6424万股，换手率0.45%，振幅5.72%。Genedx Holdings Corp.股票所在的生命科学行业中，整体涨幅为0.56%。Genedx Holdings Corp.公司简介：GeneDx Holdings Corp提供个性化且可操作的健康见解，为诊断提供信息、指导治疗并改进药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230759a2521d9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230759a2521d9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.genedx.com","stockEarnings":[{"period":"1week","weight":-0.0994},{"period":"1month","weight":-0.2994},{"period":"3month","weight":-0.5596},{"period":"6month","weight":-0.5102},{"period":"1year","weight":-0.3563},{"period":"ytd","weight":-0.5416}],"compareEarnings":[{"period":"1week","weight":0.036},{"period":"1month","weight":0.0046},{"period":"3month","weight":-0.021},{"period":"6month","weight":0.0405},{"period":"1year","weight":0.2952},{"period":"ytd","weight":-0.0036}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GeneDx Holdings Corp.是一家于2020年7月10日在特拉华州注册成立的公司，Sema4是一家以患者为中心的健康情报公司，致力于通过数据驱动的洞察力推进医疗保健。Sema4通过将人工智能和机器学习应用于多维、纵向临床和基因组数据来构建人类健康的动态模型并定义最佳的个性化健康轨迹，从而改变医疗保健。Centrellis是他们创新的健康智能平台，能够更全面地了解疾病和健康，并为最紧迫的医疗需求提供科学驱动的解决方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.104041},{"month":2,"riseRate":0.833333,"avgChangeRate":0.352675},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.143199},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.014539},{"month":5,"riseRate":0.4,"avgChangeRate":-0.013957},{"month":6,"riseRate":0.6,"avgChangeRate":0.029191},{"month":7,"riseRate":0.8,"avgChangeRate":0.138059},{"month":8,"riseRate":0.2,"avgChangeRate":-0.136267},{"month":9,"riseRate":0.2,"avgChangeRate":-0.072401},{"month":10,"riseRate":0.8,"avgChangeRate":0.18872},{"month":11,"riseRate":0.2,"avgChangeRate":-0.130294},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.04765}],"exchange":"NASDAQ","name":"GeneDx Holdings","nameEN":"GeneDx Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GeneDx Holdings(WGS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GeneDx Holdings(WGS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GeneDx Holdings,WGS,GeneDx Holdings股票,GeneDx Holdings股票老虎,GeneDx Holdings股票老虎国际,GeneDx Holdings行情,GeneDx Holdings股票行情,GeneDx Holdings股价,GeneDx Holdings股市,GeneDx Holdings股票价格,GeneDx Holdings股票交易,GeneDx Holdings股票购买,GeneDx Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GeneDx Holdings(WGS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GeneDx Holdings(WGS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}